alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
xml version="1.0" encoding="UTF-8"?


C\_2018183EN.01001701.xml


| | | | |
| --- | --- | --- | --- |
| 29.5.2018 | EN | Official Journal of the European Union | C 183/17 |

---

Prior notification of a concentration

(Case M.8496 — Strabag/Max Bögl International/SMB)

Candidate case for simplified procedure

(Text with EEA relevance)

(2018/C 183/08)

1.

On 22 May 2018, the Commission received notification of a proposed concentration pursuant to Article 4 of Council Regulation (EC) No 139/2004 [(1)](#ntr1-C_2018183EN.01001701-E0001).

This notification concerns the following undertakings:

| | |
| --- | --- |
| — | Strabag AG (‘Strabag’, Austria), |

| | |
| --- | --- |
| — | Max Bögl International SE (‘Bögl’, Germany), |

| | |
| --- | --- |
| — | SMB Construction International GmbH (‘SMB’, Germany). |

Strabag and Bögl acquire within the meaning of Article 3(1)(b) and Article 3(4) of the Merger Regulation joint control of SMB.

The concentration is accomplished by way of purchase of shares in a newly created company constituting a joint venture.

2.

The business activities of the undertakings concerned are:

—   for Strabag: all areas of the building and construction industry, especially road construction, civil engineering, project management and construction materials,

—   for Bögl: various segments of the construction industry, especially construction of public buildings, civil engineering and infrastructure,

—   for SMB: construction of inclining curves for proving grounds for automobiles.

3.

On preliminary examination, the Commission finds that the notified transaction could fall within the scope of the Merger Regulation. However, the final decision on this point is reserved.

Pursuant to the Commission Notice on a simplified procedure for treatment of certain concentrations under the Council Regulation (EC) No 139/2004 [(2)](#ntr2-C_2018183EN.01001701-E0002) it should be noted that this case is a candidate for treatment under the procedure set out in the Notice.

4.

The Commission invites interested third parties to submit their possible observations on the proposed operation to the Commission.

Observations must reach the Commission not later than 10 days following the date of this publication. The following reference should always be specified:

M.8496 — Strabag/Max Bögl International/SMB

Observations can be sent to the Commission by email, by fax, or by post. Please use the contact details below:

| |
| --- |
| Email: COMP-MERGER-REGISTRY@ec.europa.eu |
| Fax +32 22964301 |
| Postal address: |
| European Commission |
| Directorate-General for Competition |
| Merger Registry |
| 1049 Bruxelles/Brussel |
| BELGIQUE/BELGIË |

---

[(1)](#ntc1-C_2018183EN.01001701-E0001)  [OJ L 24, 29.1.2004, p. 1](http://publications.europa.eu/resource/oj/JOL_2004_024_R_TOC) (the ‘Merger Regulation’).

[(2)](#ntc2-C_2018183EN.01001701-E0002)  [OJ C 366, 14.12.2013, p. 5](http://publications.europa.eu/resource/oj/JOC_2013_366_R_TOC).

---
Brian BURKE, Petitioner v. NEW YORK CITY TRANSIT AUTHORITY, et al.

No. 19-562

Supreme Court of the United States.

January 13, 2020

Petition for writ of certiorari to the United States Court of Appeals for the Second Circuit denied.
**Exhibit
      32.2**




**CERTIFICATION
      OF PRINCIPAL FINANCIAL OFFICER PURSUANT TO 18 U.S.C. ss.
      1350**





**(SECTION
      906 OF THE SARBANES-OXLEY ACT OF 2002)**





I,
      Li Chi
      Yuen, Chief Financial Officer of China-Biotics, Inc. (the "Registrant"), certify
      pursuant to 18 U.S.C. ss. 1350, as adopted pursuant to ss. 906 of the
      Sarbanes-Oxley Act of 2002, that, based upon a review of the Quarterly Report
      on
      Form 10-QSB for the period ended December 31, 2006 of the Registrant (the
      "Report"):





(1)
            The
                Report fully complies with the requirements of Section 13(a) or 15(d)
                of
                The Securities Exchange Act of 1934, as amended;
                and








(2)
            The
                information contained in the Report fairly presents, in all material
                respects, the financial condition and results of operations of the
                Registrant.





A
      signed
      original of this written statement required by Section 906 has been provided
      to
      the Registrant and will be retained by the Registrant and furnished to the
      Securities and Exchange Commission or its staff upon request.








/s/
      Li
      Chi Yuen


____________________________


Li
      Chi
      Yuen


Chief
      Financial Officer


February
      12, 2007
```

[Congressional Bills 113th Congress]
[From the U.S. Government Publishing Office]
[H. Con. Res. 123 Enrolled Bill (ENR)]

        H.Con.Res.123
                                     Agreed to December 12, 2014        

                     One Hundred Thirteenth Congress

                                 of the

                        United States of America

                          AT THE SECOND SESSION

           Begun and held at the City of Washington on Friday,
           the third day of January, two thousand and fourteen

                          Concurrent Resolution

    Resolved by the House of Representatives (the Senate concurring), 
That, in the enrollment of the bill H.R. 3979, the Clerk of the House 
of Representatives shall make the following correction: In section 
1207(e)(2), strike ``categories I, II, III, VII, and X'' and insert 
``categories I, II, III, VII, X, XI, and XIII''.
Attest:

                                 Clerk of the House of Representatives.

Attest:

                                               Secretary of the Senate.
```
EXHIBIT
32.2





Certification
of the Chief Financial Officer


Pursuant
to 18 U.S.C. Section 1350,


as
adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002





In
connection with the Quarterly Report of K-Fed Bancorp (the “Company”) on Form
10-Q for the period ended December 31, 2009 as filed with the Securities and
Exchange Commission on the date hereof (the “Report”), I, Dustin Luton, Chief
Financial Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350,
as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 and in
connection with this quarterly report on Form 10-Q that:





1.
            The
      Report fully complies with the requirements of sections 13(a) or 15(d) of
      the Securities Exchange Act of 1934, as amended, and2.
            The
      information contained in the report fairly presents, in all material
      respects, the company’s financial condition and results of
      operations.











Date:
      February 9, 2010
            /s/ Dustin LutonDustin
      LutonChief
      Financial Officer
FORD MOTOR COMPANY, Petitioner v. MONTANA EIGHTH JUDICIAL DISTRICT COURT, et al.

No. 19-368

Supreme Court of the United States.

January 17, 2020

Petition for writ of certiorari to the Supreme Court of Montana and to the Supreme Court of Minnesota granted. The case is consolidated, and a total of one hour is allotted for oral argument.
MICHAEL CETTA, INC., dba Sparks Restaurant, Petitioner v. NATIONAL LABOR RELATIONS BOARD

No. 19-628

Supreme Court of the United States.

January 13, 2020

Petition for writ of certiorari to the United States Court of Appeals for the District of Columbia Circuit denied.
Exhibit 32.1

                        CERTIFICATION OF PERIODIC REPORT

Pursuant to 18 U.S.C.  Section 1350,  as adopted  pursuant to Section 906 of the
Sarbanes-Oxley  Act of  2002,  each  of the  undersigned  officers  of  Veridium
Corporation (the "Company"), certifies that:

     1.   The  Quarterly  Report  on Form  10-QSB of the  Company  for the three
          months ended March 31, 2004 (the  "Report")  fully  complies  with the
          requirements of Section 13(a) or 15(d) of the Securities  Exchange Act
          of 1934 (15 U.S.C. 78m or 78o(d)); and

     2.   The  information  contained  in the  Report  fairly  presents,  in all
          material respects,  the financial  condition and results of operations
          of the Company.




VERIDIUM CORPORATION


                    /S/      JAMES F. GREEN
                    -----------------------
By:                          JAMES F. GREEN
                             Chief Executive Officer
Date:                        August 15, 2005


                    /S/      MICHAEL DESROSIERS
                    ---------------------------
By:                          MICHAEL DESROSIERS
                             Chief Financial Officer
Date:                        August 15, 2005


This  certification  is made solely for the purpose of 18 U.S.C.  Section  1350,
subject  to the  knowledge  standard  contained  therein,  and not for any other
purpose.
Independent Auditors' Consent



To the Shareholders and Board of Directors of
Greenwich Street Municipal Fund Inc.:

We consent to the use of our report dated July 14, 1997 for the 
Greenwich Street Municipal Fund Inc. incorporated herein by 
reference and to the references to our Firm under the headings 
"Financial Highlights" and "Experts" in the Prospectus and 
"Independent Public Accountants" in the Statement of Additional 
Information.
 



	KPMG Peat Marwick 
LLP


New York, New York
September 12, 1997
William GAUDET, Petitioner v. UNITED STATES.

No. 19-6509

Supreme Court of the United States.

December 9, 2019

Petition for writ of certiorari to the United States Court of Appeals for the First Circuit denied.
SUBSIDIARY SIDE LETTER



 Exhibit 4.13 
  
 LAURUS MASTER FUND, LTD. 
 825 Third Avenue, 14th Floor 
 New York, New York 10022 
  
 February 10, 2004 
  
 Innovative
Companies, Inc. 
 6950 Bryon Dairy Road 
 Largo, FL 33777 
 Attn: Mr. Jay Taneja 
  
 Re: Restricted Account Number
2000016904583 at Wachovia Bank, N.A. 
  
 Reference is made to
that certain Securities Purchase Agreement dated as of February 10, 2004 by and among Innovative Companies, Inc. (“Parent”), Innovative Companies, Inc. Subsidiary (“Subsidiary”) and Laurus Master Fund, Ltd.
(“Purchaser”) (the “Purchase Agreement”). Capitalized terms used but not defined herein shall have the meanings ascribed them in the Purchase Agreement. Pursuant to the Section 9.4 of the Purchase Agreement, Subsidiary is
required to place $4,799,750 in a restricted account (the “Restricted Account”) at a bank reasonably acceptable to the Purchaser, maintain such amount in the restricted account for as long as the Purchaser shall hold any Preferred Shares
and to pledge the restricted account to Purchaser as security for the performance of the Parent’s obligations to Purchaser. 
  
 Purchaser and Parent desire to clarify certain aspects regarding the use of funds contained in the Restricted Account, and for good consideration, the
receipt and sufficiency of which is here acknowledged, the Parent and the Purchaser agree that: 
  
 (1) within three (3) business days of any conversion of Preferred Stock into the common stock of the Parent (a “Conversion”), Laurus shall
direct Wachovia Bank, N.A. to wire an amount of funds equal to the corresponding dollar amount of such Conversion from the Restricted Account to such accounts as Parent may direct Laurus in writing; and 
  
 (2) Laurus shall be entitled to instruct Wachovia Bank, N.A. to wire funds
from the Restricted Account to North Fork Bank only as such direction directly relates to Conversions. 







 If the foregoing meets with your approval please signify your acceptance of the terms hereof by signing
below. 
  

	
	 Signed,

	
	 Laurus Master Fund, Ltd.

	
	 By:




  

	
	 Agreed and Accepted this 10th day of February, 2004.

	
	 Innovative Companies, Inc.

	
	 By:
Nasser GHELICHKHANI, Petitioner v. UNITED STATES

No. 18-9783

Supreme Court of the United States.

December 16, 2019

Petition for rehearing denied.

Justice Kagan took no part in the consideration or decision of this petition.
Richard PARRISH, Petitioner v. UNITED STATES

No. 19-5123

Supreme Court of the United States.

October 7, 2019

Petition for writ of certiorari to the United States Court of Appeals for the Sixth Circuit denied.
# Official Journal C 134/2006

| | ISSN 1725-2555 |
| --- | --- |
| Official Journal
  of the European Union | C 134 |
| | |
| English edition | Information and Notices | Volume 498 June 2006 |

ISSN 1725-2555

Official Journal

of the European Union

C 134

English edition

Information and Notices

Volume 498 June 2006

---

| Notice No | Contents | page |
| --- | --- | --- |
| | I   Information |
| | Commission |
| 2006/C 134/1 | Commission communication in the framework of the implementation of the Council Directive 89/106/EEC of 21 December 1988 on the approximation of laws, regulations and administrative provisions of the Member States relating to construction products (Publication of titles and references of harmonised standards under the directive) (1) | 1 |

Notice No

Contents

page

I   Information

Commission

2006/C 134/1

Commission communication in the framework of the implementation of the Council Directive 89/106/EEC of 21 December 1988 on the approximation of laws, regulations and administrative provisions of the Member States relating to construction products (Publication of titles and references of harmonised standards under the directive) (1)

1

---

| | |
| --- | --- |
| | (1)   Text with EEA relevance. |

---

(1)   Text with EEA relevance.

1

| EN | |
| --- | --- |

EN
Christina ALESSIO, Petitioner v. UNITED AIRLINES, INC.

No. 19-395

Supreme Court of the United States.

November 25, 2019

Petition for writ of certiorari to the United States Court of Appeals for the Sixth Circuit denied.
Adrienne MALLARD, Petitioner v. NEXT DAY TEMPS, et al.

No. 19-6782

Supreme Court of the United States.

January 27, 2020

Petition for writ of certiorari to the Supreme Court of Virginia denied.
**Exhibit 32.1**

**CERTIFICATIONPURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002**

In connection with theQuarterly Report of Physicians Formula Holdings, Inc. (the “Company”) on Form10-Q for the period ended September 30, 2006, as filed with the Securities andExchange Commission (the “Report”), I, Ingrid Jackel, Chief Executive Officerof the Company, certify, pursuant to 18 U.S.C. §1350, as adopted pursuant to§906 of the Sarbanes-Oxley Act of 2002, that:

(1)          The Reportfully complies with the requirements of Section 13(a) or 15(d) of theSecurities Exchange Act of 1934; and

(2)          Theinformation contained in the Report fairly presents, in all material respects,the financial condition and results of operations of the Company.

The foregoing certification is being furnishedsolely pursuant to 18 U.S.C. §1350 and is not being filed as part of the Reportor as a separate disclosure document.

Date: December 20, 2006
| By:    | /s/ Ingrid Jackel       |   |
|--------|-------------------------|--------|
| Name:  | Ingrid Jackel           |   |
| Title: | Chief Executive Officer |   |

A signed original of this written statementrequired by Section 906, or other document authenticating, acknowledging, orotherwise adopting the signature that appears in typed form within the electronicversion of this written statement required by Section 906, has been provided toPhysicians Formula Holdings, Inc. and will be retained by Physicians FormulaHoldings, Inc. and furnished to the Securities and Exchange Commission or itsstaff upon request.

 

----
To the Shareholders and Board of Directors of
Smith Barney Investment Trust:

In planning and performing our audits of the financial statements of Smith
Barney U.S. 5000 Index Fund and Smith Barney International Index Fund
(formerly Smith Barney EAFE Fund) (collectively the "Funds") for the year
ended December 31, 2000, we considered their internal control, including
control activities for safeguarding securities, in order to determine our
auditing procedures for the purpose of expressing our opinion on the
financial statements and to comply with the requirements of Form N-SAR, not
to provide assurance on internal control.

The management of the Funds is responsible for establishing and maintaining
internal control.  In fulfilling this responsibility, estimates and
judgments by management are required to assess the expected benefits and
related costs of controls.  Generally, controls that are relevant to an
audit pertain to the entity's objective of preparing financial statements
for external purposes that are fairly presented in conformity with
accounting principles generally accepted in the United States of America.
Those controls include the safeguarding of assets against unauthorized
acquisition, use, or disposition.

Because of inherent limitations in internal control, error or fraud may
occur and not be detected.  Also, projection of any evaluation of internal
control to future periods is subject to the risk that it may become
inadequate because of changes in conditions or that the effectiveness of
the design and operation may deteriorate.

Our consideration of internal control would not necessarily disclose all
matters in internal control that might be material weaknesses under
standards established by the American Institute of Certified Public
Accountants.  A material weakness is a condition in which the design or
operation of one or more of the internal control components does not reduce
to a relatively low level the risk that misstatements caused by error or
fraud in amounts that would be material in relation to the financial
statements being audited may occur and not be detected within a timely
period by employees in the normal course of performing their assigned
functions.  However, we noted no matters involving internal control and its
operation, including controls for safeguarding securities, that we consider
to be material weaknesses as defined above as of December 31, 2000.

This report is intended solely for the information and use of management,
the Board of Directors of Smith Barney Investment Trust and the Securities
and Exchange Commission and is not intended to be and should not be used by
anyone other than these specified parties.


San Francisco, California
February 9, 2001
Gerald ARANOFF, Petitioner v. Susan ARANOFF;

No. 18-9390

Supreme Court of the United States.

December 9, 2019

Petition for rehearing denied.
Daniel WERT, Petitioner v. Ronnie R. HOLT, Warden

No. 19-6708

Supreme Court of the United States.

January 13, 2020

Petition for writ of certiorari to the United States Court of Appeals for the Third Circuit denied.
```
 
 
CRUDE OIL, LIGHT SWEET-WTI - ICE FUTURES EUROPE                      Code-067411
FUTURES ONLY POSITIONS AS OF 08/26/14                         |
--------------------------------------------------------------| NONREPORTABLE
      NON-COMMERCIAL      |   COMMERCIAL    |      TOTAL      |   POSITIONS
--------------------------|-----------------|-----------------|-----------------
  LONG  | SHORT  |SPREADS |  LONG  | SHORT  |  LONG  | SHORT  |  LONG  | SHORT
--------------------------------------------------------------------------------
(CONTRACTS OF 1,000 BARRELS)                         OPEN INTEREST:      453,578
COMMITMENTS
  79,381   36,711  117,549  237,476  288,212  434,406  442,472   19,172   11,106

CHANGES FROM 08/19/14 (CHANGE IN OPEN INTEREST:    -14,052)
  -3,926   -1,775   -2,558   -1,377   -2,756   -7,861   -7,089   -6,191   -6,963

PERCENT OF OPEN INTEREST FOR EACH CATEGORY OF TRADERS
    17.5      8.1     25.9     52.4     63.5     95.8     97.6      4.2      2.4

NUMBER OF TRADERS IN EACH CATEGORY (TOTAL TRADERS:      133)
      39       27       55       63       61      125      122
```

----

Updated August 29, 2014
Diego Portocarrero VALENCIA, Petitioner v. UNITED STATES

No. 18-9328

Supreme Court of the United States.

December 9, 2019

Petition for writ of certiorari to the United States Court of Appeals for the Eleventh Circuit denied.
Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### Securities and Exchange Commission

          - [Release No. 34-95074; File No. SR-CboeBZX-2022-017]

                    On March 7, 2022, Cboe BZX Exchange, Inc. (the “Exchange”) filed with the Securities and Exchange Commission (“Commission”), pursuant to Section 19(b)(1) of the Securities Exchange Act of 1934 (“Act”) [1]                                          and Rule 19b-4 thereunder,[2]                                          a proposed rule change to (i) make the current clearly erroneous execution (“CEE”) pilot program permanent, and (ii) limit the circumstances where CEE reviews would continue to be available during Regular Trading Hours. The proposed rule change was published for comment in the                     **Federal Register**                     on March 11, 2022.[3]                                          On April 19, 2022, the Commission designated a longer period for Commission action on the proposed rule change, until June 9, 2022.[4]                                          The Commission has received no comment letters on the proposal.                

On June 8, 2022, the Exchange withdrew the proposed rule change (File No. SR-CboeBZX-2022-017).

                        For the Commission, by the Division of Trading and Markets, pursuant to delegated authority.[5] 

J. Matthew DeLesDernier,

Assistant Secretary.

# Footnotes

1.                             15 U.S.C. 78s(b)(1).                    
        Back to Citation      

2.                             17 CFR 240.19b-4.                    
        Back to Citation      

3.                                                     *See*                         Securities Exchange Act Release No. 94374 (March 7, 2022), 87 FR 14062.                    
        Back to Citation      

4.                                                     *See*                         Securities Exchange Act Release No. 94744, 87 FR 24351 (April 25, 2022).                    
        Back to Citation      

5.                                 17 CFR 200.30-3(a)(12).                        
        Back to Citation      

[FR Doc. 2022-12838 Filed 6-14-22; 8:45 am]

BILLING CODE 8011-01-P